# Structural Insights into HLA-DQ–Associated Susceptibility to Celiac Disease Through an Integrated Genetic and In Silico Approach in a Sardinian Population

**Authors:** Faustina Barbara Cannea, Daniela Diana, Rossano Rossino, Alessandra Padiglia

PMC · DOI: 10.3390/genes17020145 · Genes · 2026-01-28

## TL;DR

This study explores how genetic and structural features of HLA-DQ molecules influence celiac disease risk in a Sardinian population.

## Contribution

The study integrates genetic data with in silico structural analysis to reveal structural differences in HLA-DQ alleles linked to celiac disease.

## Key findings

- CD patients showed a marked enrichment of the DR3–DQ2.5 haplotype.
- HLA-DQ2.5 displayed a more coherent secondary structure compared to DQ2.2.
- Structural coherence in HLA-DQ molecules is linked to disease susceptibility.

## Abstract

Background: Celiac disease (CD) is a multifactorial autoimmune disorder strongly associated with specific HLA class II molecules, particularly HLA-DQ–encoding haplotypes. Although the genetic contribution of these loci is well established, the structural features accompanying allele-specific disease susceptibility remain incompletely explored. Methods: In this study, molecular HLA typing was integrated with in silico secondary structure analysis to examine the relationship between genetic predisposition and structural organization of HLA class II molecules in a Sardinian population. A total of 100 patients with CD and 100 healthy controls were genotyped for HLA-DR and HLA-DQ alleles, and allelic and haplotypic distributions were compared between groups. Secondary structure predictions were performed using PSIPRED on selected HLA class II alleles, focusing on groove-forming domains of HLA-DRB1 and HLA-DQA1. Results: CD patients showed a marked enrichment of the DR3–DQ2.5 haplotype, together with a population-specific predominance of DQ2.5 and a reduced contribution of DQ8. Secondary structure analysis of the HLA-DRB1 β1 domain revealed a largely conserved organization, with only modest allele-dependent variations. In contrast, comparative analysis of HLA-DQA1 identified localized differences within the α1 domain, with the DQ2.5 molecule displaying a more coherent secondary structure organization compared with the lower-risk DQ2.2 variant. Conclusions: By integrating genetic and in silico structural analyses, this study highlights that HLA-associated susceptibility to celiac disease reflects not only allele and haplotype distribution but also subtle, allele-specific features in the structural organization of peptide-binding regions. These findings provide a refined framework for interpreting HLA-DQ–mediated genetic risk and support the relevance of structural coherence as a complementary dimension in the assessment of disease susceptibility.

## Linked entities

- **Genes:** HLA-DRB1 (major histocompatibility complex, class II, DR beta 1) [NCBI Gene 3123], HLA-DQA1 (major histocompatibility complex, class II, DQ alpha 1) [NCBI Gene 3117]
- **Diseases:** celiac disease (MONDO:0005130)

## Full-text entities

- **Genes:** HLA-C (major histocompatibility complex, class I, C) [NCBI Gene 3107] {aka D6S204, HLA-JY3, HLAC, HLC-C, MHC, PSORS1}, HLA-DRB4 (major histocompatibility complex, class II, DR beta 4) [NCBI Gene 3126] {aka DR4, DRB4, HLA-DR4B, HLA-DRB, HLA-DRB4*}, HLA-DRB1 (major histocompatibility complex, class II, DR beta 1) [NCBI Gene 3123] {aka DRB1, HLA-DR1B, HLA-DRB, SS1}, HLA-DQA1 (major histocompatibility complex, class II, DQ alpha 1) [NCBI Gene 3117] {aka CELIAC1, DQ-A1, DQA1, HLA-DQA, HLA-DQA1*}, HP (haptoglobin) [NCBI Gene 3240] {aka HP2ALPHA2, HPA1S}, HLA-DQB1 (major histocompatibility complex, class II, DQ beta 1) [NCBI Gene 3119] {aka CELIAC1, HLA-DQB, IDDM1}, TOR1A (torsin family 1 member A) [NCBI Gene 1861] {aka AMC5, DQ2, DYT1}, HLA-DMA (major histocompatibility complex, class II, DM alpha) [NCBI Gene 3108] {aka D6S222E, DMA, HLADM, RING6}, TNFRSF25 (TNF receptor superfamily member 25) [NCBI Gene 8718] {aka APO-3, DDR3, DR3, LARD, TNFRSF12, TR3}, CD4 (CD4 molecule) [NCBI Gene 920] {aka CD4mut, IMD79, Leu-3, OKT4D, T4}, CD74 (CD74 molecule) [NCBI Gene 972] {aka CLIP, DHLAG, HLADG, II, Ia-GAMMA, p33}, TGM2 (transglutaminase 2) [NCBI Gene 7052] {aka G(h), TG(C), TGC, hTG2, tTG}, HLA-DPB1 (major histocompatibility complex, class II, DP beta 1) [NCBI Gene 3115] {aka DPB1, HLA-DP, HLA-DP1B, HLA-DPB}, HLA-A (major histocompatibility complex, class I, A) [NCBI Gene 3105] {aka HLAA}
- **Diseases:** injury to (MESH:D014947), anxiety (MESH:D001007), autoimmune (MESH:D001327), autoimmune enteropathy (MESH:C538273), CD (MESH:D002446), villous atrophy (MESH:C564019), crypt hyperplasia (MESH:D006965)
- **Chemicals:** glutamic acid (MESH:D018698), deamidated gliadin (-), silica (MESH:D012822), glutamine (MESH:D005973), agarose (MESH:D012685)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12940421/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12940421/full.md

## References

53 references — full list in the complete paper: https://tomesphere.com/paper/PMC12940421/full.md

---
Source: https://tomesphere.com/paper/PMC12940421